NSEOutcome of Board Meeting2d ago · 4 Nov 2026, 01:58 pm

Outcome of Board Meeting

Jyothy Labs Limited · JYOTHYLAB

✦ AI SummaryResults

Jyothy Labs Limited has announced its unaudited financial results for the quarter and half-year ended September 30, 2026, and has also approved a buyback of up to 68,37,210 equity shares at a price of ₹215 per share.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Jyothy Labs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Attachments (1)

📄

JYOTHYLAB_04112026135026_SEIntimationOutcomeBM.pdf

pdf

Download →
View document text
Jyothy labs November 04, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Sandra - Kurla Complex, Dalal Street, Mumbai - 400 001 Sandra (E), Mumbai -400 051 BSE Scrip Code: 532926 NSE Symbol: JYOTHYLAB Dear Sir/ Madam, Sub: Outcome of the Board Meeting held on November 4, 2026 pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"). Further to our letters dated October 13, 2026 and October 30, 2026 and in terms of Regulation 30 of SEBI Listing Regulations, we wish to inform you that the Board of the Company, at its meeting held today i.e., November 4, 2026, which commenced at 11 :00 a.m. and concluded at I • .l.tO p.m., has inter-alia, considered and approved: 1. Unaudited Financial Results and Statements for the quarter and half-year ended September 30, 2026: The Unaudited Financial Results for the quarter and half-year ended September 30, 2026, with the Limited Review Report by the Statutory Auditors of the Company. Accordingly, in terms of Regulation 33 of the SEBI Listing Regulations, enclosed herewith is a copy of the Un-audited Financial Results for the quarter and half-year ended September 30, 2026, accompanied with the Limited Review Report by the Statutory Auditors of the Company. Refer Annexure A. 2. Buyback of Equity Shares of Jyothy Labs Limited ("the Company") through tender offer route: The proposal to buyback up to 68,37,210 (Sixty Eight Lakhs Thirty- Seven Thousand Two Hundred and Ten) fully paid-up equity shares of the Company, having face value of ~1/- (Indian Rupees One only) each ("Equity Shares"), representing 1.86 % of the total number of equity shares in the total paid-up equity share capital of the Company as at March 31, 2026, at a price of~ 215 (Indian Rupees Two Hundred And Fifteen Only) per Equity Share ("Buyback Price"), payable in cash, for an aggregate amount of up to 147,00,00, 150 (Indian Rupees One Hundred Forty-Seven Crore One Hundred Fifty only) ("Buyback Size") (excluding any expenses incurred or to be incurred for the buyback, such as, brokerage, turnover charges, filing fees to SEBI, stock exchange Jyothy Labs Limited CIN: L24240MH1992PLC128651 'Ujala House', Ramkrishna Mandir Road, Kondivita. Andheri (East), Mumbai 400 059. Tel: +91 022-6689 2800 info@jyothy.com I www.jyothylabs.com • Jyothy labs charges, advisory fees, legal fees, intermediaries' fees, statutory auditor's fees, certification charges, public announcement publication expenses, printing and dispatch expenses, applicable taxes such as securities transaction tax, goods and services tax, stamp duty etc. and other incidental and related expenses ("Transaction Costs"). The Buyback Size represents 9.70% of the aggregate of the fully paid-up equity share capital and free reserves of the Company as per the audited financial statements for the financial year ended March 31, 2026, and is within the statutory limit of 10% of the aggregate of the fully paid-up equity share capital and free reserves under the Board approval route, ("Buyback"). The Buyback is proposed to be made from all eligible equity shareholders/beneficial owners of the Equity Shares of the Company as on the Record Date (as mentioned below), in accordance with the provisions contained in the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended ("Buyback Regulations") and the Companies Act, 2013, as amended and rules made thereunder; 3. The Board has noted that the promoter and promoter group of the Company have vide a letter dated November 4, 2026 expressed their intention not to participate in the Buyback. 4. The formation of a buyback committee ("Buyback Committee") and delegated its powers to the Buyback Committee to do all such acts, deeds, matters and things as it may, in its absolute discretion, deem necessary, expedient, usual or proper in connection with the Buyback; 5. Wednesday, November 11, 2026 as the record date ("Record Date") for the purpose of determining the entitlement and the names of equity shareholders/ beneficial owners of Equity Shares who shall be eligible to participate in the Buyback, pursuant to Regulation 42 of the SEBI Listing Regulations, as amended, and Regulation 9(i) of the SEBI Buyback Regulations, as amended. In terms of Regulation 5(via) of the Buyback Regulations, the Board/Buyback Committee may, till 1 (one) working day prior to the Record Date, increase the Buyback Price and decrease the number of Equity Shares proposed to be bought back, such that there is no change in the Buyback Size. The pre-Buyback shareholding pattern as on October 30, 2026, is enclosed as Annexure 8. Please note that the details regarding the post-Buyback shareholding pattern have not been provided since the actual number of Equity Shares that are bought back and category of shareholders from whom the Equity Shares will be bought back can be determined after the Record Date. The public announcement and the letter of offer setting out the process, timelines, and other requisite details will be released in due course in accordance with the Buyback Regulations. The relevant details as per S~E-B-~I · Master Circular No. HO/49/14/14(7)2025-CFD POD/2/1 /3762/2026 dated January ~Q,"'"2026, are given as Annexure C. Jyothy Labs Limited /""'-"". CIN: L24240MH1992PLC128651 ( 'Ujala House', Ramkrishna Mandir Road, Kondivita, Andheri (East), Mumbai 400 059. Tel: +91 022-6689 2800 0 211'1'\' info@jyothy.com I www.jyothylabs.com • Jyothy labs Kindly take the above on your record and disseminate the same for the information of investors. Thanking you, Yours faithfully, For Jyothy Labs Limited TC)) YNl,i. ~- - Shreyas Trivedi · Head - Legal & Company Secretary Jyothy Labs Limited CIN: L24240MH1992PLC128651 'Ujala House', Ramkrishna Mandir Road. Kondivita. Andheri (East). Mumbai 400 059. Tel: +91 022-6689 2800 info@jyothy.com I www.jyothylabs.com A N N -r~v e G- A BS R & Co. LLP 14th Floor, Central B Wing and North C Wing Nesco IT Park 4, Nesco Center Western Express Highway Chartered Accountants Goregaon (East), Mumbai - 400 063, India Telephone: +91 (22) 6257 1000 Fax: +91 (22) 6257 1010 Limited Review Report on unaudited financial results of J_yothy Labs Limited for the quarter ended 30 September 2026 and year to date results for the period from 1 April 2026 to 30 September 2026 pursuant to Regulation 33 of Securities and Exchange Board of India {Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Jyothy Labs Limited 1. We have reviewed the accompanying Statement of unaudited financial results of Jyothy Labs Limited (hereinafter referred to as "the Company") for the quarter ended 30 September 2026 and year to date results for the period from 1 April 2026 to 30 September 2026 ("the Statement"). 2. This Statement, which is the responsibility of the Company's management and approved by its Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("Listing Regulations"). Our responsibility is to issue a report on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accoun [Showing first 8,000 characters — download PDF for full document]